Quarterly report · Q3

Period2023-01-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥30.4bn2023-01-01 → 2023-09-30Cons.Net sales
Revenue¥34.3bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥24.9bn2022-01-01 → 2022-09-30Cons.Net sales
Operating income¥3.2bn2023-01-01 → 2023-09-30Cons.Operating income
Operating income¥555m2022-01-01 → 2022-09-30Cons.Operating income
Ordinary income¥4.0bn2023-01-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥2.6bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2022-01-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥4.0bn2023-01-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥2.5bn2022-01-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥2.7bn2023-01-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.0bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.9bn2023-01-01 → 2023-09-30Cons.Profit loss
Net income¥1.6bn2022-01-01 → 2022-09-30Cons.Profit loss
Total assets¥141.5bnat 2023-09-30Cons.Assets
Total assets¥138.1bnat 2022-12-31Cons.Assets
Total assets¥134.8bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥50.6bnat 2023-09-30Cons.Liabilities
Total liabilities¥53.6bnat 2022-12-31Cons.Liabilities
Net assets / equity¥90.9bnat 2023-09-30Cons.Net assets
Net assets / equity¥84.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥83.2bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥29.3bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥30.5bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥81.752023-01-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.962023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.912022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.672022-01-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥11.532022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.5%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio50.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio51.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 50
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-09-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-09-30¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-09-30¥274m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-09-30¥113m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-09-30−¥297m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-09-30−¥297m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-09-30−¥845m
jpcrp040300-q3r_E00524-000Machinery Businessreportable segmentrevenue2023-01-01 → 2023-09-30¥5.4bn
jpcrp040300-q3r_E00524-000Machinery Businessreportable segmentrevenue external2023-01-01 → 2023-09-30¥5.4bn
jpcrp040300-q3r_E00524-000Machinery Businessreportable segmentsegment profit2023-01-01 → 2023-09-30¥73m
jpcrp040300-q3r_E00524-000Pharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-09-30¥9.5bn
jpcrp040300-q3r_E00524-000Pharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-09-30¥9.5bn
jpcrp040300-q3r_E00524-000Pharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-09-30−¥61m
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentrevenue2023-01-01 → 2023-09-30¥8.1bn
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentrevenue external2023-01-01 → 2023-09-30¥8.1bn
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentrevenue intersegment2023-01-01 → 2023-09-30¥22m
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentsegment profit2023-01-01 → 2023-09-30¥3.3bn
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentrevenue2023-01-01 → 2023-09-30¥5.6bn
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentrevenue external2023-01-01 → 2023-09-30¥5.5bn
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentrevenue intersegment2023-01-01 → 2023-09-30¥0
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentsegment profit2023-01-01 → 2023-09-30¥627m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-09-30¥30.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-09-30¥30.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-01-01 → 2023-09-30¥297m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-09-30¥4.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-09-30¥1.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-09-30¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-09-30¥181m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-09-30¥134m
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-09-30−¥204m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-09-30−¥204m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥675m
jpcrp040300-q3r_E00524-000Machinery Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥4.4bn
jpcrp040300-q3r_E00524-000Machinery Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥4.4bn
jpcrp040300-q3r_E00524-000Machinery Businessreportable segmentsegment profit2022-01-01 → 2022-09-30−¥191m
jpcrp040300-q3r_E00524-000Pharmaceuticals Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥6.5bn
jpcrp040300-q3r_E00524-000Pharmaceuticals Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥6.5bn
jpcrp040300-q3r_E00524-000Pharmaceuticals Businessreportable segmentsegment profit2022-01-01 → 2022-09-30−¥2.0bn
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥7.8bn
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥7.8bn
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥22m
jpcrp040300-q3r_E00524-000Real Estate Businessreportable segmentsegment profit2022-01-01 → 2022-09-30¥3.0bn
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentrevenue2022-01-01 → 2022-09-30¥5.0bn
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentrevenue external2022-01-01 → 2022-09-30¥5.0bn
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥0
jpcrp040300-q3r_E00524-000Textiles Businessreportable segmentsegment profit2022-01-01 → 2022-09-30¥341m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-09-30¥25.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-09-30¥24.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-01-01 → 2022-09-30¥204m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 387
ItemContextValueUnit
Voting rights (text)FilingDateInstantText · Plus
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember
Original text (Japanese)同上
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)1単元(100株)未満の株式
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)片倉工業株式会社
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)東京都中央区明石町6番4号
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Notes changes in scope of consolidation or equity method (text)CurrentYTDDurationText · Plus
Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes regarding promissory notes due on balance sheet date (text)CurrentQuarterInstantText · Plus
Debtors notes regarding overdraft contracts and or loan commitments (text)CurrentQuarterInstantText · Plus
Notes regarding impairmet loss notes quarterly consolidated statement of income (text)CurrentYTDDurationText · Plus
Notes regarding special retirement expenses (text)CurrentYTDDurationText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes when there is significant changes in amounts of equity (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes when there is significant changes in amounts of equity (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass